Predictors of Cord Blood Immunoglobin E (IgE) Levels

Sponsor
Min-Sheng General Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00902096
Collaborator
(none)
800
1

Study Details

Study Description

Brief Summary

Background: Increased total serum IgE levels are a common characteristic of atopic diseases. Increased cord blood IgE levels, in conjunction with a family history of atopy, are associated with the development of allergic diseases in children. However, little is known about predictors of cord blood IgE levels.

Objective: The aim of our study was to identify predictors of cord blood IgE levels in an ongoing large birth cohort of infants with or without a family history of atopy.

Methods: Blood sampling of mothers was performed just before the delivery of newborns. Cord blood was also collected when the child was born. Maternal and cord blood was measured for IgE levels and cytokines. Questionnaires were administered after birth of the infant.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    800 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Study Start Date :
    Apr 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    Prenatal factors

    Prenatal factors to predict cord blood IgE

    Outcome Measures

    Primary Outcome Measures

    1. cord blood IgE [at birth]

    Secondary Outcome Measures

    1. Cord blood cytokines or other mediators [at birth]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Mothers in pregnancy 18 years of age or older, AND

    • Mothers able to speak Chinese.

    Exclusion Criteria:
    • Infant delivered at less than 36 weeks' gestation,

    • Infant with Apgar score in 5 minutes after birth < 7,

    • Infant with a major congenital anomaly, OR

    • Infant admitted to an intensive care unit.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Min-Sheng General Hospital Taoyuan Taiwan

    Sponsors and Collaborators

    • Min-Sheng General Hospital

    Investigators

    • Principal Investigator: Chien-Han Chen, MD, Min-Sheng General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00902096
    Other Study ID Numbers:
    • 2009008
    First Posted:
    May 14, 2009
    Last Update Posted:
    May 14, 2009
    Last Verified:
    May 1, 2009
    Keywords provided by , ,

    Study Results

    No Results Posted as of May 14, 2009